Screener
Celldex Therapeutics CLDX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.92B.
The source filing: Celldex Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091984
FAQ
- What is Celldex Therapeutics's market capitalization?
- Celldex Therapeutics (CLDX) reported market capitalization of $2.92B in Q2 2026.
- How has Celldex Therapeutics's market capitalization changed year-over-year?
- Celldex Therapeutics's market capitalization increased by 103.2% year-over-year, from $1.44B to $2.92B.
- What is the long-term trend for Celldex Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Celldex Therapeutics's market capitalization has grown at a 17.2% compound annual growth rate (CAGR), from $817.55M to $1.8B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Celldex Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude